Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001235802-05-000093
Filing Date
2005-08-25
Accepted
2005-08-25 15:32:27
Documents
1
Period of Report
2005-07-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 4042
  Complete submission text file 0001235802-05-000093.txt   5970
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 4600 HIGHLANDS PARKWAY SUITE A & B SMYRNA GA 30082 7708059769
BELL STEVEN J (Reporting) CIK: 0001241292 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 051048785